Medication Guide App

Label Changes for:

Augmentin (amoxicillin/clavulanate potassium) Tablets, 250 mg/125mg and 500 mg/125 mgAugmentin (amoxicillin/clavulanate potassium) Powder for Oral SuspensionAugmentin (amoxicillin/clavulanate potassium) Chewable TabletsAugmentin (amoxicillin/clavulanate potassium) Tablets, 875mg/125 mgAugmentin (amoxicillin/clavulanate potassium) Oral SuspensionAugmentin (amoxicillin/clavulanate potassium) Chewable Tablets

January 2013

Changes have been made to the PRECAUTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)

Augmentin (amoxicillin/clavulanate potassium) Tablets, 250 mg/125mg and 500 mg/125 mg
Augmentin (amoxicillin/clavulanate potassium) Powder for Oral Suspension
Augmentin (amoxicillin/clavulanate potassium) Chewable Tablets
Augmentin (amoxicillin/clavulanate potassium) Tablets, 875mg/125 mg
Augmentin (amoxicillin/clavulanate potassium) Oral Suspension
Augmentin (amoxicillin/clavulanate potassium) Chewable Tablets

 

January 2013

DRUG INTERACTIONS

7.2 Oral Anticoagulants
  • Abnormal prolongation of prothrombin time (increased international normalized ratio [INR]) has been reported in patients receiving amoxicillin and oral anticoagulants. Appropriate monitoring should be .....
Hide
(web4)